Home > Resources > Whitepapers > Biofuels a contribution to an informed discussion

Biofuels a contribution to an informed discussion

For more than 40 years, biofuels have been an important source of alternative energy but it was not until 5-7 years ago policies in the U.S. and other places brought about the steep increase in biofuel production. Once hailed as the one technology capable of decarbonizing the transportation sector, later accused for being unsustainable, biofuels is today a bewildering technology to most people.

I'm For Real

Enter your details once to access all our information and resources

Spotlight

Cell Sciences, Inc.

For nearly two decades Cell Sciences has been a worldwide provider of the highest quality research antibodies, proteins and immunoassay kits available for use in life science research. We offer a wide range of products for research in human, non-human primate, and small and large animal models. These products include: native & recombinant proteins, chemokines & cytokines, cytokine receptors, kinases, phosphatases, ELISA & ELISPOT kits, monoclonal & polyclonal antibodies and matched antibody pairs for ELISA & ELISPOT assays.

OTHER WHITEPAPERS
news image

How advanced purification technologies are speeding the hunt for new protections against disease

whitePaper | November 24, 2022

Smallpox was the first infectious disease for which an effective vaccine was developed. In the late 1700s, British doctor Edward Jenner devised a method to inoculate people with cowpox pus to give them immunity against smallpox, a much more deadly disease.

Read More
news image

6 Strategies to Stimulate Patient Engagementin Rehab Therapy

whitePaper | August 25, 2022

Patient engagement has become a measure of healthcare analytics that many in rehab therapy have sought to quantify.

Read More
news image

Using Clinical Breakpoints to Improve Antimicrobial Resistance Detection

whitePaper | December 13, 2022

Define the ongoing pandemic of antimicrobial resistance. Discuss how we can address the ongoing pandemicin the Clinical Microbiology Laboratory

Read More
news image

Small Molecule Apis Made with Compelling Science

whitePaper | July 17, 2023

As your API demand grows, we grow with you. While we can manufacture volumes in metric tons, we can also go small. If you have a chemistry-based compound and need smaller batches for clinical or commercial use, we can offer the quantities you need at our cGMP small-scale/pilot facilities until you’re ready for full-scale manufacturing.

Read More
news image

Document quality control emerges as a discipline in its own right

whitePaper | November 19, 2022

Compiling a quality regulatory submission is a basic requirement for biopharmaceutical companies. Poor quality documents could lead to rejection of a regulatory application,

Read More
news image

Bioanalytical Techniques to Advance Biosimilars Development

whitePaper | August 22, 2022

Biosimilar therapies offer more unique approaches to treating patients with serious diseases, such as cancer.

Read More

How advanced purification technologies are speeding the hunt for new protections against disease

whitePaper | November 24, 2022

Smallpox was the first infectious disease for which an effective vaccine was developed. In the late 1700s, British doctor Edward Jenner devised a method to inoculate people with cowpox pus to give them immunity against smallpox, a much more deadly disease.

Read More

6 Strategies to Stimulate Patient Engagementin Rehab Therapy

whitePaper | August 25, 2022

Patient engagement has become a measure of healthcare analytics that many in rehab therapy have sought to quantify.

Read More

Using Clinical Breakpoints to Improve Antimicrobial Resistance Detection

whitePaper | December 13, 2022

Define the ongoing pandemic of antimicrobial resistance. Discuss how we can address the ongoing pandemicin the Clinical Microbiology Laboratory

Read More

Small Molecule Apis Made with Compelling Science

whitePaper | July 17, 2023

As your API demand grows, we grow with you. While we can manufacture volumes in metric tons, we can also go small. If you have a chemistry-based compound and need smaller batches for clinical or commercial use, we can offer the quantities you need at our cGMP small-scale/pilot facilities until you’re ready for full-scale manufacturing.

Read More

Document quality control emerges as a discipline in its own right

whitePaper | November 19, 2022

Compiling a quality regulatory submission is a basic requirement for biopharmaceutical companies. Poor quality documents could lead to rejection of a regulatory application,

Read More

Bioanalytical Techniques to Advance Biosimilars Development

whitePaper | August 22, 2022

Biosimilar therapies offer more unique approaches to treating patients with serious diseases, such as cancer. 

Read More
More Whitepapers

Spotlight

Cell Sciences, Inc.

For nearly two decades Cell Sciences has been a worldwide provider of the highest quality research antibodies, proteins and immunoassay kits available for use in life science research. We offer a wide range of products for research in human, non-human primate, and small and large animal models. These products include: native & recombinant proteins, chemokines & cytokines, cytokine receptors, kinases, phosphatases, ELISA & ELISPOT kits, monoclonal & polyclonal antibodies and matched antibody pairs for ELISA & ELISPOT assays.

Events